214 related articles for article (PubMed ID: 21875931)
1. ADAM12 produced by tumor cells rather than stromal cells accelerates breast tumor progression.
Fröhlich C; Nehammer C; Albrechtsen R; Kronqvist P; Kveiborg M; Sehara-Fujisawa A; Mercurio AM; Wewer UM
Mol Cancer Res; 2011 Nov; 9(11):1449-61. PubMed ID: 21875931
[TBL] [Abstract][Full Text] [Related]
2. ADAM12 and ADAM17 gene expression in laser-capture microdissected and non-microdissected breast tumors.
Narita D; Seclaman E; Ilina R; Cireap N; Ursoniu S; Anghel A
Pathol Oncol Res; 2011 Jun; 17(2):375-85. PubMed ID: 21240579
[TBL] [Abstract][Full Text] [Related]
3. A role for ADAM12 in breast tumor progression and stromal cell apoptosis.
Kveiborg M; Fröhlich C; Albrechtsen R; Tischler V; Dietrich N; Holck P; Kronqvist P; Rank F; Mercurio AM; Wewer UM
Cancer Res; 2005 Jun; 65(11):4754-61. PubMed ID: 15930294
[TBL] [Abstract][Full Text] [Related]
4. ADAM12 is expressed in the tumour vasculature and mediates ectodomain shedding of several membrane-anchored endothelial proteins.
Fröhlich C; Klitgaard M; Noer JB; Kotzsch A; Nehammer C; Kronqvist P; Berthelsen J; Blobel C; Kveiborg M; Albrechtsen R; Wewer UM
Biochem J; 2013 May; 452(1):97-109. PubMed ID: 23458101
[TBL] [Abstract][Full Text] [Related]
5. ADAM12 is highly expressed in carcinoma-associated stroma and is required for mouse prostate tumor progression.
Peduto L; Reuter VE; Sehara-Fujisawa A; Shaffer DR; Scher HI; Blobel CP
Oncogene; 2006 Aug; 25(39):5462-6. PubMed ID: 16607276
[TBL] [Abstract][Full Text] [Related]
6. ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinoma.
Cheon DJ; Li AJ; Beach JA; Walts AE; Tran H; Lester J; Karlan BY; Orsulic S
Carcinogenesis; 2015 Jul; 36(7):739-47. PubMed ID: 25926422
[TBL] [Abstract][Full Text] [Related]
7. ADAM12 redistributes and activates MMP-14, resulting in gelatin degradation, reduced apoptosis and increased tumor growth.
Albrechtsen R; Kveiborg M; Stautz D; Vikeså J; Noer JB; Kotzsh A; Nielsen FC; Wewer UM; Fröhlich C
J Cell Sci; 2013 Oct; 126(Pt 20):4707-20. PubMed ID: 24006261
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic diversity of breast cancer-related mutations in metalloproteinase-disintegrin ADAM12.
Qi Y; Duhachek-Muggy S; Li H; Zolkiewska A
PLoS One; 2014; 9(3):e92536. PubMed ID: 24651654
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of ADAM12 and ADAM17 genes in laser-capture microdissected breast cancers and correlations with clinical and pathological characteristics.
Narita D; Seclaman E; Ursoniu S; Anghel A
Acta Histochem; 2012 Feb; 114(2):131-9. PubMed ID: 21501859
[TBL] [Abstract][Full Text] [Related]
10. ADAM12 transmembrane and secreted isoforms promote breast tumor growth: a distinct role for ADAM12-S protein in tumor metastasis.
Roy R; Rodig S; Bielenberg D; Zurakowski D; Moses MA
J Biol Chem; 2011 Jun; 286(23):20758-68. PubMed ID: 21493715
[TBL] [Abstract][Full Text] [Related]
11. The role of SnoN in transforming growth factor beta1-induced expression of metalloprotease-disintegrin ADAM12.
Solomon E; Li H; Duhachek Muggy S; Syta E; Zolkiewska A
J Biol Chem; 2010 Jul; 285(29):21969-77. PubMed ID: 20457602
[TBL] [Abstract][Full Text] [Related]
12. ADAM12 induces estrogen-independence in breast cancer cells.
Roy R; Moses MA
Breast Cancer Res Treat; 2012 Feb; 131(3):731-41. PubMed ID: 21387162
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta1-mediated activation of NF-kappaB contributes to enhanced ADAM-12 expression in mammary carcinoma cells.
Ray A; Dhar S; Ray BK
Mol Cancer Res; 2010 Sep; 8(9):1261-70. PubMed ID: 20688878
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer-associated mutations in metalloprotease disintegrin ADAM12 interfere with the intracellular trafficking and processing of the protein.
Dyczynska E; Syta E; Sun D; Zolkiewska A
Int J Cancer; 2008 Jun; 122(11):2634-40. PubMed ID: 18241035
[TBL] [Abstract][Full Text] [Related]
15. Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression.
Bengsch F; Buck A; Günther SC; Seiz JR; Tacke M; Pfeifer D; von Elverfeldt D; Sevenich L; Hillebrand LE; Kern U; Sameni M; Peters C; Sloane BF; Reinheckel T
Oncogene; 2014 Sep; 33(36):4474-84. PubMed ID: 24077280
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling of ADAM12 in human bladder cancer.
Fröhlich C; Albrechtsen R; Dyrskjøt L; Rudkjaer L; Ørntoft TF; Wewer UM
Clin Cancer Res; 2006 Dec; 12(24):7359-68. PubMed ID: 17189408
[TBL] [Abstract][Full Text] [Related]
17. Molecular profiling of ADAM12 gene in breast cancers.
Nariţa D; Anghel A; Seclaman E; Ilina R; Cireap N; Ursoniu S
Rom J Morphol Embryol; 2010; 51(4):669-76. PubMed ID: 21103624
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the serine/threonine p70S6 kinase in TGF-beta1-induced ADAM12 expression in cultured human hepatic stellate cells.
Le Pabic H; L'Helgoualc'h A; Coutant A; Wewer UM; Baffet G; Clément B; Théret N
J Hepatol; 2005 Dec; 43(6):1038-44. PubMed ID: 16139919
[TBL] [Abstract][Full Text] [Related]
19. Adam12 plays a role during uterine decidualization in mice.
Zhang L; Guo W; Chen Q; Fan X; Zhang Y; Duan E
Cell Tissue Res; 2009 Dec; 338(3):413-21. PubMed ID: 19841944
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of a breast cancer-associated mutation in the intracellular domain of the metalloprotease ADAM12.
Stautz D; Wewer UM; Kveiborg M
PLoS One; 2012; 7(5):e37628. PubMed ID: 22662180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]